Ubs Asset Management Americas Inc Dr Reddys Laboratories LTD Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 51,492 shares of RDY stock, worth $754,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,492
Previous 16,511
211.86%
Holding current value
$754,872
Previous $260,000
161.15%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$157 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$135 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$133 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$128 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$90.9 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.43B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...